TCL Archive Five-Year Course of Tamoxifen Remains Standard Treatment In HR+ Breast Cancer July 26, 2002
TCL Archive In Brief: US Pharmacopeia Names Advisory Panel For Hematologic And Oncological Disease May 31, 1996
TCL Archive Penn Begins Clinical Trial Of A Vaccine For Breast Cancer Based On Telomerase February 27, 2004